Within this context, elafin and the secretory leucocyte protease inhibitor (SLPI), being a member of the serine protease inhibitor family, which also includes AAT, may be used to potentiate the action of AAT or to act as substitutes in case of AAT deficiency. This evidence concerns the gene PI3 and alpha 1-antitrypsin deficiency.